These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 34763944)

  • 1. Structure-guided optimization of 1H-imidazole-2-carboxylic acid derivatives affording potent VIM-Type metallo-β-lactamase inhibitors.
    Yan YH; Li W; Chen W; Li C; Zhu KR; Deng J; Dai QQ; Yang LL; Wang Z; Li GB
    Eur J Med Chem; 2022 Jan; 228():113965. PubMed ID: 34763944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sulfamoyl Heteroarylcarboxylic Acids as Promising Metallo-β-Lactamase Inhibitors for Controlling Bacterial Carbapenem Resistance.
    Wachino JI; Jin W; Kimura K; Kurosaki H; Sato A; Arakawa Y
    mBio; 2020 Mar; 11(2):. PubMed ID: 32184250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, Synthesis, and Biological Evaluation of New 1H-Imidazole-2-Carboxylic Acid Derivatives as Metallo-β-Lactamase Inhibitors.
    Li R; Su H; Chen W; Yan YH; Zhou C; Mou L; Yang H; Qian S; Wang Z; Yang L; Li GB
    Bioorg Med Chem; 2022 Oct; 72():116993. PubMed ID: 36084491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. H
    Chen F; Bai M; Liu W; Kong H; Zhang T; Yao H; Zhang E; Du J; Qin S
    Eur J Med Chem; 2021 Nov; 224():113702. PubMed ID: 34303873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural studies of triazole inhibitors with promising inhibitor effects against antibiotic resistance metallo-β-lactamases.
    Muhammad Z; Skagseth S; Boomgaren M; Akhter S; Fröhlich C; Ismael A; Christopeit T; Bayer A; Leiros HS
    Bioorg Med Chem; 2020 Aug; 28(15):115598. PubMed ID: 32631568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanistic Investigations of Metallo-β-lactamase Inhibitors: Strong Zinc Binding Is Not Required for Potent Enzyme Inhibition*.
    Wade N; Tehrani KHME; Brüchle NC; van Haren MJ; Mashayekhi V; Martin NI
    ChemMedChem; 2021 May; 16(10):1651-1659. PubMed ID: 33534956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metallo-β-lactamase inhibitors by bioisosteric replacement: Preparation, activity and binding.
    Skagseth S; Akhter S; Paulsen MH; Muhammad Z; Lauksund S; Samuelsen Ø; Leiros HS; Bayer A
    Eur J Med Chem; 2017 Jul; 135():159-173. PubMed ID: 28445786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and enzyme-based evaluation of analogues
    Khalili Arjomandi O; Kavoosi M; Adibi H
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1414-1425. PubMed ID: 31401901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and Preclinical Evaluation of TPA-Based Zinc Chelators as Metallo-β-lactamase Inhibitors.
    Schnaars C; Kildahl-Andersen G; Prandina A; Popal R; Radix S; Le Borgne M; Gjøen T; Andresen AMS; Heikal A; Økstad OA; Fröhlich C; Samuelsen Ø; Lauksund S; Jordheim LP; Rongved P; Åstrand OAH
    ACS Infect Dis; 2018 Sep; 4(9):1407-1422. PubMed ID: 30022668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitroxoline and its derivatives are potent inhibitors of metallo-β-lactamases.
    Proschak A; Martinelli G; Frank D; Rotter MJ; Brunst S; Weizel L; Burgers LD; Fürst R; Proschak E; Sosič I; Gobec S; Wichelhaus TA
    Eur J Med Chem; 2022 Jan; 228():113975. PubMed ID: 34865870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroxyhexylitaconic acids as potent IMP-type metallo-β-lactamase inhibitors for controlling carbapenem resistance in
    Wachino J-i; Jin W; Norizuki C; Kimura K; Tsuji M; Kurosaki H; Arakawa Y
    Microbiol Spectr; 2024 Mar; 12(3):e0234423. PubMed ID: 38315122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of 1-Hydroxypyridine-2(1H)-thione-6-carboxylic Acid as a First-in-Class Low-Cytotoxic Nanomolar Metallo β-Lactamase Inhibitor.
    Shin WS; Bergstrom A; Bonomo RA; Crowder MW; Muthyala R; Sham YY
    ChemMedChem; 2017 Jun; 12(11):845-849. PubMed ID: 28482143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro comparative activity of the new beta-lactamase inhibitor taniborbactam with cefepime or meropenem against Klebsiella pneumoniae and cefepime against Pseudomonas aeruginosa metallo-beta-lactamase-producing clinical isolates.
    Meletiadis J; Paranos P; Georgiou PC; Vourli S; Antonopoulou S; Michelaki A; Vagiakou E; Pournaras S
    Int J Antimicrob Agents; 2021 Nov; 58(5):106440. PubMed ID: 34551356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting clinically-relevant metallo-β-lactamases: from high-throughput docking to broad-spectrum inhibitors.
    Brindisi M; Brogi S; Giovani S; Gemma S; Lamponi S; De Luca F; Novellino E; Campiani G; Docquier JD; Butini S
    J Enzyme Inhib Med Chem; 2016; 31(sup1):98-109. PubMed ID: 27121013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of 2-Aminothiazole-4-carboxylic Acids as Broad-Spectrum Metallo-β-lactamase Inhibitors by Mimicking Carbapenem Hydrolysate Binding.
    Yan YH; Zhang TT; Li R; Wang SY; Wei LL; Wang XY; Zhu KR; Li SR; Liang GQ; Yang ZB; Yang LL; Qin S; Li GB
    J Med Chem; 2023 Oct; 66(19):13746-13767. PubMed ID: 37791640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ((S)-3-Mercapto-2-methylpropanamido)acetic acid derivatives as metallo-β-lactamase inhibitors: Synthesis, kinetic and crystallographic studies.
    Liu S; Jing L; Yu ZJ; Wu C; Zheng Y; Zhang E; Chen Q; Yu Y; Guo L; Wu Y; Li GB
    Eur J Med Chem; 2018 Feb; 145():649-660. PubMed ID: 29353720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and investigation of inhibitory activities of imidazole derivatives against the metallo-β-lactamase IMP-1.
    Khalili Arjomandi O; Kavoosi M; Adibi H
    Bioorg Chem; 2019 Nov; 92():103277. PubMed ID: 31539743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 4-Amino-1,2,4-triazole-3-thione-derived Schiff bases as metallo-β-lactamase inhibitors.
    Gavara L; Sevaille L; De Luca F; Mercuri P; Bebrone C; Feller G; Legru A; Cerboni G; Tanfoni S; Baud D; Cutolo G; Bestgen B; Chelini G; Verdirosa F; Sannio F; Pozzi C; Benvenuti M; Kwapien K; Fischer M; Becker K; Frère JM; Mangani S; Gresh N; Berthomieu D; Galleni M; Docquier JD; Hernandez JF
    Eur J Med Chem; 2020 Dec; 208():112720. PubMed ID: 32937203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the Offensive: the Role of Outer Membrane Vesicles in the Successful Dissemination of New Delhi Metallo-β-lactamase (NDM-1).
    Martínez MMB; Bonomo RA; Vila AJ; Maffía PC; González LJ
    mBio; 2021 Oct; 12(5):e0183621. PubMed ID: 34579567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NOTA analogue: A first dithiocarbamate inhibitor of metallo-β-lactamases.
    Zhang E; Wang MM; Huang SC; Xu SM; Cui DY; Bo YL; Bai PY; Hua YG; Xiao CL; Qin S
    Bioorg Med Chem Lett; 2018 Jan; 28(2):214-221. PubMed ID: 29248295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.